Drug Trial Radar · NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
980
Planned (sponsor's estimate)
Start
Oct 8, 2025
Primary completion
May 9, 2028
Study completion May 9, 2028
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- Collaborators
- Teva Branded Pharmaceutical Products R&D LLC
- First posted
- Sep 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC). Study details include: The study duration may be up to 35 weeks with: * Screening period * 12-week Sub-Study 1 (Single-Arm Open-Label Feeder Induction) or Sub-Study 2 (Pivotal Induction) * 12-week Sub-Study 3 (Extended Induction for non-responders) * 45 days follow-up visit for participants who do not enroll into the maintenance study (EFC18359) The treatment duration will be up to 12 weeks in each sub-study. The number of scheduled on-site visits will be up to 8 for the Sub-Study 1 and Sub Study 2 or a maximum of 15 visits for participants completing extended induction.
Conditions
- Ulcerative Colitis
Interventions
DuvakitugDrug
Pharmaceutical form:Solution for Injection-Route of administration:SC injection
PlaceboDrug
Pharmaceutical form:Solution for injection-Route of administration:SC injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants achieving clinical remission.Time frame: Week 12
Locations
240 sites in 25 countries. Site status is shown where the registry gives one.
Onyx Clinical Research - Site Number: 8400021
Peoria, Arizona · Recruiting
One of a Kind Clinical Research Center LLC - Site Number: 8400061
Scottsdale, Arizona · Recruiting
Scottsdale Clinical Trials - Site Number: 8400145
Scottsdale, Arizona · Recruiting
Del Sol Research Management, LLC - Site Number: 8400012
Tucson, Arizona · Recruiting
Preferred Research Partners - Site Number: 8400018
Little Rock, Arkansas · Recruiting
FOMAT - Unio Specialty Care Arcadia - Site Number: 8400027
Arcadia, California · Recruiting
Alliance Research Institute - Site Number: 8400008
Canoga Park, California · Recruiting
Southern California GI & Liver Centers - Site Number: 8400062
Coronado, California · Recruiting
GMC Clinical Research, LLC - Site Number: 8400113
Folsom, California · Recruiting
Om Research, LLC - Lancaster - Site Number: 8400148
Lancaster, California · Recruiting
TLC Clinical Research Inc. - Site Number: 8400030
Los Angeles, California · Recruiting
United Medical Doctors CA - Site Number: 8400044
Murrieta, California · Recruiting
Om Research, LLC - Oxnard - Site Number: 8400150
Oxnard, California · Recruiting
UC Davis Health System - Site Number: 8400071
Sacramento, California · Recruiting
Clinical Applications Laboratories Inc - Site Number: 8400056
San Diego, California · Recruiting
Medical Associates Research Group - Site Number: 8400063
San Diego, California · Recruiting
Santa Maria Gastroenterology - FOMAT Medical Research HyperCORE - Site Number: 8400025
Santa Maria, California · Recruiting
Valiance Clinical Research - Tarzana - Site Number: 8400023
Tarzana, California · Recruiting
Clinical Trials Management Services - Site Number: 8400047
Thousand Oaks, California · Recruiting
Amicis Research Center-Valencia -Site Number: 8400064
Valencia, California · Recruiting
Om Research, LLC - Victorville - Site Number: 8400022
Victorville, California · Recruiting
UCHealth Digestive Health Center - Anschutz Medical Campus - Site Number: 8400085
Aurora, Colorado · Recruiting
Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039
Colorado Springs, Colorado · Recruiting
Gastroenterology of the Rockies - Denver - Site Number: 8400122
Denver, Colorado · Recruiting
Yale University Digestive Disease - Site Number: 8400108
New Haven, Connecticut · Recruiting
Novum Research, LLC - Site Number: 8400003
Clermont, Florida · Recruiting
Precision Clinical Research-Site Number: 8400059
Coral Springs, Florida · Recruiting
Sarkis Clinical Trials-Ocala - Site Number: 8400048
Gainesville, Florida · Recruiting
Clinical Research of Osceola - Site Number: 8400013
Kissimmee, Florida · Recruiting
Columbus Clinical Services LLc - Site Number: 8400038
Miami, Florida · Recruiting
Regis Clinical Research, LLC - Site Number: 8400041
Miami, Florida · Recruiting
Sylvester Comprehensive Cancer Center - A University of Miami Hospital and Clinics Facility - Miami - Site Number: 8400111
Miami, Florida · Recruiting
Bio Research Partner - Site Number: 8400053
Miami, Florida · Recruiting
Medical Professional Clinical Research Center - Site Number: 8400119
Miami, Florida · Recruiting
Paradisus Med Research - Site Number: 8400036
Miami, Florida · Recruiting
Correa Research Center-Site Number: 8400010
Miami, Florida · Recruiting
Orlando Health, Inc. - Site Number: 8400084
Orlando, Florida · Recruiting
AdventHealth Orlando - Site Number: 8400070
Orlando, Florida · Recruiting
Tropical Clinical Trials - Site Number: 8400082
Palmetto Bay, Florida · Recruiting
NMC Research LLC - Site Number: 8400033
Tampa, Florida · Recruiting
Showing 40 of 240 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.